.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Citi
Moodys
Argus Health
Chinese Patent Office
Cantor Fitzgerald
Farmers Insurance
McKesson
Novartis
Daiichi Sankyo

Generated: July 24, 2017

DrugPatentWatch Database Preview

RIMIFON Drug Profile

« Back to Dashboard

Which patents cover Rimifon, and when can generic versions of Rimifon launch?

Rimifon is a drug marketed by Roche and is included in one NDA.

The generic ingredient in RIMIFON is isoniazid. There are five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

Summary for Tradename: RIMIFON

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list86
Patent Applications: see list8,119
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIMIFON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
RIMIFON
isoniazid
INJECTABLE;INJECTION008420-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
RIMIFON
isoniazid
INJECTABLE;INJECTION008420-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
RIMIFON
isoniazid
SYRUP;ORAL008420-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Accenture
Fish and Richardson
Chubb
Medtronic
McKinsey
Citi
Fuji
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot